Related Experiment Videos
Monoclonals and allergy. A review, with experimental contribution
A Albertini1, E Antoniazzi, S Archetti
1Istituto di Chimica e Propedeutica Biochimica, Università degli Studi di Brescia.
Summary
Monoclonal antibodies show promise in allergy research and immunotherapy monitoring. This study reviews their development, standardization, and experimental application in allergology, paving the way for new vaccines.
Area of Science:
- Immunology
- Allergology
- Biotechnology
Background:
- Monoclonal antibodies (mAbs) represent a significant advancement in biological research and therapeutic applications.
- Their development involves sophisticated technologies, and their application in allergology is rapidly expanding.
- Standardization of mAbs is crucial for reliable diagnostic and therapeutic use in allergy.
Purpose of the Study:
- To review the current state of monoclonal antibody research and development.
- To explore the impact and applications of monoclonal antibodies in the field of allergology.
- To present experimental findings on the preparation and characterization of allergenic extracts for monoclonal antibody development.
Main Methods:
- Review of existing literature on monoclonal antibody technology and applications.
- Description of the preparation of specific allergenic extracts (D.F.).
- Detailed explanation of experimental steps including rabbit immunization, extract characterization, and monoclonal antibody screening and characterization techniques.
Main Results:
- The study outlines the general principles and technologies for developing monoclonal antibodies.
- It details the specific methods used for preparing and characterizing allergenic extracts.
- Results from monoclonal screening and characterization are discussed, evaluating the advantages and disadvantages of employed techniques.
Conclusions:
- Monoclonal antibodies are valuable tools in allergy research and have potential in monitoring immunotherapy.
- The experimental work provides a foundation for developing novel diagnostic and therapeutic strategies, including anti-idiotype vaccines.
- Further research and standardization are necessary to fully leverage the potential of monoclonal antibodies in allergy management.